MHE Question of the Week: Should the Medicare Cap Be Extended?
Should the Medicare $2,000 per year cap on out-of-pocket costs for prescription drugs be extended to commercial insurance?
One of the most important provisions of the Inflation Reduction Act caps the out-of-pocket prescription drug costs of Medicare Beneficiaries. A $3,250 cap went into effect this year and will be lowered to $2,000 next year. But the limit only applies to those with Part D Medicare coverage, the part of Medicare that covers prescription drugs. President Joe Biden proposed extending the cap to health insurance sold on the commercial market in his State of the Union speech last week. Proponents of such limits say they make high-priced medications affordable, improving access to drugs that can reduce illness and lengthen lives. Detractors say limits will make premiums more expensive and also have long-term negative effects on the development of drugs.
Should the Medicare $2,000 per year cap on out-of-pocket costs for prescription drugs be extended to commercial insurance?
Please pick the statement that most closely resembles your view
Should the Medicare $2,000 per-year cap on out-of-pocket costs for prescription drugs be extended to commercial insurance?
We want to know what you’re thinking! Every Monday morning the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. Answers will be published every Friday.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
